cardiotoxicity

Teske AJ, Moudgil R, López-Fernández T, Barac A, Brown SA, Deswal A, Neilan TG, Ganatra S, Abdel Qadir H, Menon V, Sverdlov AL, Cheng RK, ...

Agarwal S, Guha A, Krishan S, Naqash AR, Addison D, Yang EH, Barac A, Asad ZUA. Statins for Primary Prevention of Anthracycline Chemotherapy-Related Cardiac Dysfunction: ...

Natterson-Horowitz B, Linde A. Cardiomyopathy Across the Tree of Life: Insights for Clinicians and Investigators. Circ Heart Fail. 2023 Jul 26:e010485. doi: 10.1161/CIRCHEARTFAILURE.123.010485. Epub ahead ...

Patel SR, Suero-Abreu GA, Ai A, Ramachandran MK, Meza K, Florez N. Inequity in care delivery in cardio-oncology: dissecting disparities in underrepresented populations. Front Oncol. ...

Chen J, Chapski DJ, Jong J, Awada J, Wang Y, Slamon DJ, Vondriska TM, Packard RRS. Integrative transcriptomics and cell systems analyses reveal protective pathways ...

Packard RRS, Yang EH. Editorial: Novel mechanisms, imaging approaches, and management strategies for anthracycline-induced cardiotoxicity. Front Cardiovasc Med. 2023 Jan 4;9:1109078. doi: 10.3389/fcvm.2022.1109078. PMID: 36684589; ...

Ganatra S, Dani SS, Yang EH, Zaha VG, Nohria A. Cardiotoxicity of T-Cell Antineoplastic Therapies: JACC: CardioOncology Primer. JACC CardioOncol. 2022 Dec 20;4(5):616-623. doi: 10.1016/j.jaccao.2022.07.014. PMID: 36636447; PMCID: ...

Venkatesh P, Yan KL, Bravo-Jaimes K, Yang EH, Lluri G. Outcomes of malignancy in adults with congenital heart disease: a single center experience. Cardiooncology. 2022 ...

Jong J, Pinney JR, Packard RRS. Anthracycline-induced cardiotoxicity: From pathobiology to identification of molecular targets for nuclear imaging. Front Cardiovasc Med. 2022 Aug 3;9:919719. doi: ...

Stein-Merlob AF, Ganatra S, Yang EH. T-cell Immunotherapy and Cardiovascular Disease: Chimeric Antigen Receptor T-cell and Bispecific T-cell Engager Therapies. Heart Fail Clin. 2022 Jul;18(3):443-454. ...